Medicus Pharma (MDCX) Submits Product Development Plan to the FDA to Treat External Squamous Cell Carcinoma in Horses Jun 9, 2025 07:32AM
Medicus Pharma Ltd. Announces Submission of Product Development Plan to the Food and Drug Administration (FDA) to Treat External Squamous Cell Carcinoma (SCC) in Horses Jun 9, 2025 07:30AM
Medicus Pharma (MDCX) Announces FDA Minor Use Designation for Doxorubicin-Containing Microneedle Array (D-MNA) Patch Dec 12, 2024 07:31AM
Medicus Pharma Ltd. Announces Minor Use (MUMS) Designation from the FDA for Doxorubicin-Containing Microneedle Array (D-MNA) Patch Dec 12, 2024 07:30AM